List of Excipients in API ENSITRELVIR
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ENSITRELVIR
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Shionogi Inc | XOCOVA | ensitrelvir | 59630-711 | CELLULOSE, MICROCRYSTALLINE | 2031-05-29 |
| Shionogi Inc | XOCOVA | ensitrelvir | 59630-711 | CROSCARMELLOSE SODIUM | 2031-05-29 |
| Shionogi Inc | XOCOVA | ensitrelvir | 59630-711 | HYDROXYPROPYL CELLULOSE | 2031-05-29 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ENSITRELVIR
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ENSITRELVIR drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ENSITRELVIR drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ENSITRELVIR drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ENSITRELVIR drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ENSITRELVIR drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ENSITRELVIR drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Shionogi Inc | ensitrelvir | 59630-711 |
| >Company | >Ingredient | >NDC |
ENSITRELVIR drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
